Viewing data from:

EPLERENONE

ANDA

EPLERENONE | A208283 | BRECKENRIDGE PHARMACEUTICAL INC

2 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: INSPRA(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 5 NDCs

Highest NADAC/Unit

$0.4655

per ea

Lowest NADAC/Unit

$0.3092

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
51991087833EPLERENONE 50 MG TABLET	$0.4655	EA	Generic	—	2026-06-17
51991087890EPLERENONE 50 MG TABLET	$0.4655	EA	Generic	—	2026-06-17
60687045121EPLERENONE 25 MG TABLET	$0.3092	EA	Generic	—	2026-06-17
51991087733EPLERENONE 25 MG TABLET	$0.3092	EA	Generic	—	2026-06-17
51991087790EPLERENONE 25 MG TABLET	$0.3092	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain6 active DMFs1 inactive

5 active API suppliers hold Drug Master Files for this ingredient.

INDUSTRIALE CHIMICA SRLEPLERENONE

DMF 197152006

MSN LABORATORIES PRIVATE LTDEPLERENONE [ROUTE CODE: PL]

DMF 234662010

AURISCO PHARMACEUTICAL CO LTDEPLERENONE

DMF 276722013

INDUSTRIALE CHIMICA SRLEPLERENONE PH. EUR.

DMF 329982018

HETERO LABS LTDEPLERENONE

DMF 338322019

ZHEJIANG SHENZHOU PHARMACEUTICAL CO LTDEPLERENONE API

DMF 370242022

APOTEX PHARMACHEM INCInactiveEPLERENONE MEK HEMISOLVATE (1:0.5)

DMF 197962006

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 25MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Sep 14, 2018

No patent or exclusivity listings for this strength.

#002 — 50MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Sep 14, 2018